<DOC>
	<DOCNO>NCT02434718</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability single multiple intravenous ( IV ) infusion Aducanumab Japanese participant mild moderate Alzheimer 's Disease ( AD ) . The secondary objective study follow : To evaluate serum pharmacokinetics ( PK ) Aducanumab single multiple intravenous ( IV ) infusion Aducanumab ; To evaluate effect single multiple IV infusion Aducanumab immunogenicity .</brief_summary>
	<brief_title>Single Multiple Ascending Dose Study Aducanumab ( BIIB037 ) Japanese Participants With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Key Must ambulatory Must clinical diagnosis mild moderate AD Must good health determine Investigator , base medical history Screening assessment Must caregiver , understand study assent accompany subject study site visit , provide information Investigator/study site staff , specifically cognitive ability AEs/SAEs return perprotocol followup visit procedure Must consent blood sample collection deoxyribonucleic acid ( DNA ; genotyping ) ribonucleic acid ( RNA ; potential future analysis ) . Key Any medical neurological condition ( AD ) opinion Investigator could contribute cause subject 's dementia Transient ischemic attack stroke unexplained loss consciousness within 1 year prior Screening Poorly control diabetes mellitus , define dosage adjustment diabetic medication within 3 month prior Day 1 History unstable angina , myocardial infarction , chronic heart failure Chronic , uncontrolled hypertension History seizure within 3 year prior Screening History within past 6 month evidence clinically significant psychiatric illness History severe allergic anaphylactic reaction , history hypersensitivity inactive ingredient drug product NOTE : Other protocol define Inclusion/Exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>